title: Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties.
abstract: Loading plasmid DNA into poly(ester) microparticles usually involves the formation of a multiple emulsion, using homogenisation techniques such as sonication or Ultra-Turrax. These procedures may negatively affect the integrity of the macromolecule and consequently its activity. The aim of this study was to prepare and evaluate DNA-loaded microparticles by TROMS (Total Recirculation One-Machine System), a new procedure that is based on the formation of a multiple emulsion by the injection of the phases under a turbulent regime. Microparticles were prepared with either Resomer) RG 502 (MP 502) or RG 756 (MP 756) and DNA loading was quantified fluorimetrically. DNA loading in MP 756 was almost twice as high as in MP 502 (510 vs. 285 ng/mg, respectively). Under both formulations, the loaded plasmid was released while maintaining its integrity for at least 24 days (MP 502) and 40 days (MP 756). Finally, the transfection efficiency was studied after injection of the microparticles (MP 502) into rat skeletal muscle and compared with naked DNA injection. Injection of naked DNA (150 microg DNA per muscle) achieved higher but variable expression levels that decreased after 3 weeks. In contrast, the muscles injected with microparticles (6.8 microg DNA per muscle) showed lower but homogeneous expression values, which were maintained for at least 3 weeks.
authors.affiliation: Centro Galénico, Departamento de Farmacia y Tecnología Farmacéutica, Universidad de Navarra, Irunlarrea 1, 31080, Pamplona, Spain.
authors.forename: G García
authors.initials: GG
authors.lastname: del Barrio
authors.forename: F J
authors.initials: FJ
authors.lastname: Novo
authors.forename: J M
authors.initials: JM
authors.lastname: Irache
mesh_terms: D000818:Animals; D004247:DNA / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics; D005260:Female; D019344:Lactic Acid / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics*; D008863:Microspheres; D010957:Plasmids / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics*; D011100:Polyglycolic Acid / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar; D013678:Technology, Pharmaceutical / Q000295:instrumentation* / Q000379:methods; D014162:Transfection / Q000379:methods
chemical_list: D003692:Delayed-Action Preparations; D011108:Polymers; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D004247:DNA